Harel Insurance Investments & Financial Services Ltd. Invests $1.11 Million in NanoString Technologies, Inc. (NASDAQ:NSTG)


Share on StockTwits

Harel Insurance Investments & Financial Services Ltd. acquired a new stake in NanoString Technologies, Inc. (NASDAQ:NSTG) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 7,810 shares of the biotechnology company’s stock, valued at approximately $1,114,000.

Other large investors have also recently modified their holdings of the company. Neo Ivy Capital Management bought a new stake in NanoString Technologies in the 4th quarter valued at about $47,000. Penserra Capital Management LLC lifted its position in NanoString Technologies by 211.7% in the 4th quarter. Penserra Capital Management LLC now owns 1,010 shares of the biotechnology company’s stock valued at $67,000 after purchasing an additional 686 shares during the last quarter. Nisa Investment Advisors LLC lifted its position in NanoString Technologies by 16.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,400 shares of the biotechnology company’s stock valued at $94,000 after purchasing an additional 200 shares during the last quarter. Strs Ohio bought a new stake in NanoString Technologies in the 4th quarter valued at about $140,000. Finally, Truvestments Capital LLC bought a new stake in NanoString Technologies in the 4th quarter valued at about $170,000. Hedge funds and other institutional investors own 98.33% of the company’s stock.

NanoString Technologies stock opened at $74.95 on Tuesday. The firm has a market cap of $3.39 billion, a price-to-earnings ratio of -43.83 and a beta of 1.77. NanoString Technologies, Inc. has a 1 year low of $27.46 and a 1 year high of $86.42. The firm’s 50 day moving average price is $70.50 and its two-hundred day moving average price is $63.83. The company has a debt-to-equity ratio of 1.66, a quick ratio of 8.12 and a current ratio of 8.94.

NanoString Technologies (NASDAQ:NSTG) last released its quarterly earnings data on Sunday, February 28th. The biotechnology company reported ($0.53) earnings per share for the quarter, missing the consensus estimate of ($0.49) by ($0.04). The company had revenue of $36.26 million for the quarter, compared to the consensus estimate of $35.65 million. NanoString Technologies had a negative return on equity of 68.96% and a negative net margin of 53.47%. As a group, equities analysts predict that NanoString Technologies, Inc. will post -2.77 EPS for the current fiscal year.

In other news, Director Robert Hershberg sold 1,500 shares of the stock in a transaction on Monday, March 15th. The stock was sold at an average price of $66.94, for a total value of $100,410.00. Following the completion of the sale, the director now owns 3,390 shares in the company, valued at $226,926.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP J. Chad Brown sold 4,948 shares of the stock in a transaction on Thursday, March 25th. The shares were sold at an average price of $68.78, for a total value of $340,323.44. Following the completion of the sale, the senior vice president now owns 4,037 shares of the company’s stock, valued at approximately $277,664.86. The disclosure for this sale can be found here. Insiders sold 110,323 shares of company stock valued at $7,111,682 in the last 90 days. Corporate insiders own 4.20% of the company’s stock.

Several equities analysts have commented on NSTG shares. Zacks Investment Research cut shares of NanoString Technologies from a “buy” rating to a “hold” rating in a research note on Friday, March 5th. JPMorgan Chase & Co. raised their target price on shares of NanoString Technologies from $75.00 to $80.00 and gave the company an “overweight” rating in a research note on Tuesday, March 2nd. Morgan Stanley raised their target price on shares of NanoString Technologies from $55.00 to $70.00 and gave the company an “equal weight” rating in a research note on Tuesday, March 9th. Cowen raised shares of NanoString Technologies from a “market perform” rating to an “outperform” rating and set a $75.00 target price on the stock in a research note on Wednesday, January 6th. Finally, Robert W. Baird raised their target price on shares of NanoString Technologies from $70.00 to $78.00 and gave the company an “outperform” rating in a research note on Tuesday, March 2nd. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $71.00.

NanoString Technologies Profile

NanoString Technologies, Inc develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system.

Further Reading: Does the Step Transaction Doctrine Affect a Backdoor Roth IRA?

Institutional Ownership by Quarter for NanoString Technologies (NASDAQ:NSTG)

Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.